n,n-dimethylarginine has been researched along with lansoprazole in 3 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (lansoprazole) | Trials (lansoprazole) | Recent Studies (post-2010) (lansoprazole) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 2,281 | 803 | 600 |
Protein | Taxonomy | n,n-dimethylarginine (IC50) | lansoprazole (IC50) |
---|---|---|---|
phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | 0.434 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.995 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 5.3148 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.3367 | |
WD repeat-containing protein 5 | Homo sapiens (human) | 5.9 | |
Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 5.9 | |
Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 8.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aydemir, S; Cabuk, M; Demircan, N; Eren, H; Harmandar, FA; Tekin, IO | 1 |
Cooke, JP; Erlanson, DA; Ghebremariam, YT; Lee, JC; Leiper, J; LePendu, P; Shah, NH; Slaviero, A | 1 |
Chang, P; Cooke, JP; Ghebremariam, YT; Khan, F; Leeper, NJ; Nead, KT; Shah, NH; Thakker, RN | 1 |
2 trial(s) available for n,n-dimethylarginine and lansoprazole
Article | Year |
---|---|
Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Arginine; Atherosclerosis; Cardiovascular Abnormalities; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitric Oxide Synthase Type III; Young Adult | 2010 |
Proton pump inhibitors and vascular function: A prospective cross-over pilot study.
Topics: Administration, Oral; Adult; Arginine; Biomarkers; California; Coronary Disease; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Lansoprazole; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Reproducibility of Results; Risk Assessment; Time Factors; Upper Extremity; Vasodilation; Young Adult | 2015 |
1 other study(ies) available for n,n-dimethylarginine and lansoprazole
Article | Year |
---|---|
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Proton Pump Inhibitors; Risk Factors; Vasodilation | 2013 |